AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Eb v Vaccine
We don't have a sterilizing vaxcine. We'll have to target people before they become infected of the virus. There's more interest now since the asera paper launched, and we've had about two or three companies get interested in e b v vaxine. So i'm very excited by the fact that the big vaccine companies are getting interested in making the n b b vaccine,. But i think we can have to use the vaccine as a treatment strategy rather than just develop a vaccine.